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by Topical Application of NF-jB Decoy
Oligodeoxynucleotide
Iwao Isomura1, Kunio Tsujimura2 and Akimichi Morita1
Activation and maturation of dendritic cells (DC) are crucial for the establishment of delayed-type
hypersensitivity (DTH). However, antigen presentation by immature DC (iDC) might lead to antigen-specific
peripheral tolerance. NF-kB plays significant roles in upregulation of co-stimulatory molecules and cytokines in
DC and therefore we investigated whether NF-kB decoy oligodeoxynucleotide (ODN) might induce tolerance
to DTH. NF-kB decoy ODN suppressed ovalbumin (OVA)-induced DTH responses not only in naı¨ve but also in
presensitized mice. The suppressive effect was found to be antigen-specific. NF-kB decoy ODN-induced
tolerance involved CD4þCD25þ regulatory T cells (Treg), because in vivo depletion of CD25þ T cells abrogated
the tolerance, whereas adoptive transfer of such T cell population from tolerant mice induced tolerance.
Furthermore, the induction of Treg was related to insufficient migration and/or maturation of DC, because a
sizable DC population still remained in peripheral tissue even after exposure to exogenous antigen in NF-kB
decoy ODN-treated mice. Even if they migrated into lymph nodes, they showed insufficient upregulation of
co-stimulatory molecules and impaired antigen-specific activation of T cells. Topical application of NF-kB decoy
ODN might thus be a new approach to induce antigen-specific peripheral tolerance.
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INTRODUCTION
The induction of antigen-specific immune tolerance has long
been targeted to controlling allergic or autoimmune disease
activity without immunosuppressive reagents. For analysis of
tolerance induction, we have focused on delayed-type
hypersensitivity (DTH) because this can be induced by
various antigens and applied to assess immune response
and/or tolerance in animal models and human studies.
Activation and maturation of dendritic cells (DC) are crucial
for the establishment of DTH (Banchereau and Steinman,
1998). However, an increasing number of studies have
demonstrated that antigen presentation by immature dendri-
tic cells (iDC) and certain subsets of mature DC induce
antigen-specific peripheral tolerance (Dhodapkar et al.,
2001; Hawiger et al., 2001; O’Connell et al., 2002; Sato
et al., 2003). iDC are characterized by low surface expression
of co-stimulatory molecules such as CD80 and CD86.
Meanwhile, evidence is accumulating that CD4þCD25þ
regulatory T cells (Treg) play significant roles in the
maintenance of self-tolerance, and several reports have
indicated that induction of Treg is required for tolerance to
allogeneic and exogenous antigens and for prevention of
autoimmune disorders (Takahashi et al., 1998; Kuniyasu
et al., 2000; Shevach, 2001; Taylor et al., 2001; Thorstenson
and Khoruts 2001; Zhang et al., 2001). There is evidence that
expansion of Treg by iDC is associated with tolerance
induction (Roncarolo et al., 2001).
NF-kB has emerged as a key transducer of inflammatory
signals for the DC maturation program (Li and Verma, 2002).
NF-kB complexes comprise homodimers or heterodimers of
structurally related proteins, including p50, p52, relA (p65),
c-Rel, and RelB, and are present in an inactive form in the
cytosol bound to the inhibitor protein, IkB. Inflammatory
cytokines such as IL-1 and tumor necrosis factor-a and
by-products of bacterial and viral infections promote nuclear
translocation of NF-kB by inducing phosphorylation- and
ubiquitin-dependent degradation of IkB. Activated NF-kB
then regulates various immune responses, including upregu-
lation of co-stimulatory molecules and immunostimulatory
cytokines as well as cell survival.
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Recently, oligodeoxynucleotides (ODNs) bearing consen-
sus binding sequences of specific transcription factors have
been explored as tools for manipulating gene expression on
living cells (Mann and Dzau, 2000). This strategy involves the
intracellular delivery of a ‘‘decoy’’ ODN, which occupies a
DNA-binding site and blocks subsequent binding of proteins
to the promoter regions of target genes. Based on the
immunoregulatory effects, NF-kB decoy ODN has been
investigated in several studies for prevention of myocardial
infarction, anti-inflammatory gene therapy for cystic fibrosis
patients, prevention of rheumatoid arthritis, and prolongation
of cardiac allograft survival (Morishita et al., 1997; Tomita
et al., 1999; Giannoukakis et al., 2000; Griesenbach et al.,
2000; Bonham et al., 2002). In these studies, the purpose of
employing NF-kB decoy ODN was to induce immunosup-
pressive effects in target organs, although it remained unclear
whether tolerance was induced in an antigen-specific
manner. It is therefore of great interest to determine whether
NF-kB decoy ODN can induce tolerance to DTH.
In the present study, we therefore investigated whether
topical application of NF-kB decoy ODN to the skin of BALB/
c mice would induce tolerance to DTH caused by
responsible exogenous antigens.
RESULTS
Topical application of NF-jB decoy ODN induces tolerance
to DTH
When NF-kB decoy ODN ointment (2%) was applied to the
shaved abdominal skin of BALB/c mice 24 hours before
sensitization with ovalbumin (OVA) at the same site, DTH
responses were significantly suppressed (Figure 1a). Mice
treated with scramble decoy ointment, in contrast, did not
show any suppressive effect. To analyze tolerance induction
in recall responses of DTH, all mice were first sensitized with
OVA on day 0 and then NF-kB decoy ODN was applied on
day 6, 24 hours before a second sensitization on day 7. As in
the first experiment, DTH responses were again suppressed
(Figure 1b), suggesting that NF-kB decoy ODN might induce
peripheral tolerance to OVA. To investigate whether the
effects of NF-kB decoy ODN were local or systemic, mice
were sensitized with OVA on the back after topical
application of NF-kB decoy ODN to the abdominal skin.
As DTH was suppressed only when OVA and NF-kB ODN
were applied to the same area (Figure 1c), the actions appear
to be mediated by local immunosuppression.
We next performed adoptive transfer experiments. Single-
cell suspensions were prepared from regional lymph nodes
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Figure 1. Tolerance induction to OVA-induced DTH by topical NF-jB decoy ODN treatment. (a) Suppression of DTH. NF-kB decoy ODN or scramble ODN
were applied on the shaved abdominal skin of BALB/c mice on day 0, then followed by sensitization by 1 mg OVA (day 1) and elicitation with 100 mg OVA on
day 8. Footpad thickness was measured at 24 hours after elicitation. *Po0.001 compared to sensitized mice. (b) Therapeutic effects of NF-kB decoy ODN
application in presensitized mice. All mice were sensitized by 1 mg OVA on day 0, then treated with NF-kB decoy ODN on day 6 and with a second
sensitization on day 7. Elicitation was performed on day 14. *Po0.01. (c) Local immunosuppressive effects against DTH by topical NF-kB decoy ODN
treatment. Mice were topically applied with NF-kB decoy ODN on the abdominal skin on day 0 and then sensitized with OVA on abdominal or back skin on
day 1. The DTH response was assessed as previously described. *Po0.01. (d) DTH suppression by adoptive transfer of LN cells from tolerant mice. Three days
after elicitation (day 0 in this figure), left inguinal and popliteal LNs were harvested from sensitized and tolerant mice as described in (a). Recipient mice were
administered intraveneously with 5106 LN cells in 300 ml of PBS (day 0) and sensitized (day 0) and elicited (day 7) with OVA. Sensitization was performed
2 hours after adoptive transfer of LN cells. *Po0.01.
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(LNs) from sensitized and tolerant mice as shown in Figure 1a
and transferred to naı¨ve mice via the tail vein before
sensitization and DTH elicitation. As shown in Figure 1d,
DTH was suppressed in mice receiving T cells from tolerant
mice, but not from sensitized mice. Thus, the tolerance
induced by NF-kB decoy ODN treatment is mediated by
regulatory cells.
Tolerance by topical NF-jB decoy ODN is antigen specific
We next evaluated antigen specificity of the tolerance
induced by NF-kB decoy ODN in vivo by antigen-crossing
assays. After the adoptive transfer of 5 106 LN cells from
mice tolerant to OVA or hen egg lysozyme (HEL), mice were
sensitized and elicited by these antigens in a crisscross
manner. Tolerance was observed only when the mice
receiving LN cells from tolerant mice were stimulated with
the same antigen used for tolerance induction (Figure 2).
These findings indicate that the topical NF-kB decoy ODN
induces antigen-specific tolerance in vivo.
Tolerance due to NF-jB decoy ODN is mediated by induction
of CD4þCD25þ regulatory T cells
To determine whether CD4þCD25þ Treg population is
responsible for tolerance induction in our system, we first
employed in vivo depletion experiments using anti-CD25
mAb (PC61). Inhibition of DTH by NF-kB decoy ODN was
almost completely abrogated by PC61 treatment, indicating
the involvement of CD25þ T cells in the suppression (Figure
3a). PC61 treatment in sensitized and naı¨ve mice had neither
stimulatory nor suppressive effects on DTH (Figure 3a and
data not shown). To investigate the percentage of
CD4þCD25þ T cells in each group, LN cells from naı¨ve,
sensitized, and tolerant mice were analyzed by FACS (Figure
3b). The value was largest in tolerant mice but the number in
sensitized mice was also increased. Mean fluorescence
intensity of CD25 expression on CD4þCD25þ T cells,
however, was significantly increased in tolerant mice but not
in sensitized mice (Figure 3f), suggesting a qualitative
difference between the two CD4þCD25þ populations.
To confirm that CD4þCD25þ T cells were responsible for
the tolerance, CD4þCD25þ and CD4þCD25 T cell
populations were prepared using magnetic beads and
transferred to OVA-sensitized mice. The results showed the
DTH response to be suppressed in mice that had received
with CD4þCD25þ T cells from sensitized and tolerant mice,
but not naı¨ve mice (Figure 4). No suppressive effects were
observed in mice injected with CD4þCD25 T cells.
Together with the results shown in Figure 3, these findings
imply that the topical application of NF-kB decoy ODN in
combination with OVA sensitization could induce OVA-
specific tolerance through efficient activation of the pre-
existing OVA-specific Treg population. The unexpected
suppressive effects against DTH observed in the mice
receiving CD4þCD25þ T cells from sensitized mice may
reflect CD4þCD25þ enrichment effects, as adoptive transfer
of unfractionated LN cells from sensitized mice did not
suppress DTH responses, suggesting the frequency of Treg in
sensitized mice to be substantially lower than that of tolerant
mice as shown in Figure 1d. In addition to enrichment effects,
a certain CD4þCD25þ Treg population might be activated
even in the absence of NF-kB decoy ODN, as only a weak
suppressive effect against DTH was observed with
CD4þCD25þ T cells from naı¨ve mice (Figure 4). Alterna-
tively, other regulatory CD4þ T cell populations (Groux,
2003) expressing CD25 as an activation marker might be
activated.
NF-jB decoy ODN inhibits migration and maturation of DC
In general, activation and polarization of T cells are
orchestrated by antigen-presenting cells such as DC (Ban-
chereau and Steinman, 1998). Langerhans cells play the roles
in capturing, processing, and presenting antigens to T cells in
draining LNs. Recently, several reports provided evidence
that iDC lacking expression of co-stimulatory molecules and
immunostimulatory cytokines can induce tolerance (Lutz and
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Figure 2. Tolerance by topical NF-jB decoy ODN treatment is antigen-
specific. Donor mice were treated with or without NF-kB decoy ODN on day
10, sensitized with OVA (1 mg) or HEL (500 mg) on day 9 and then elicited
on day 2. Three days after elicitation (day 1), LN cells from donor mice with
(tolerant) or without (sensitized) NF-kB decoy ODN were prepared for
adoptive transfer (day 1). Naı¨ve recipient mice received LN cells on day 1 and
sensitized by injecting either antigen (1 mg OVA or 500 mg HEL) 2 hours after
adoptive transfer. Then the mice were elicited with the same antigens used for
sensitization (100 mg OVA or 50 mg HEL) into the left footpad on day 8 and
DTH was assessed. For the positive controls, some recipient mice were
treated with NF-kB decoy on day 0 and followed by sensitization and
elicitation. The time course of each step of this experiment is shown in the
lower part. *P¼ 0.036 compared to controls sensitized with HEL. **Po0.01
compared to the OVA-sensitized controls.
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Schuler, 2002). We postulated that topical application of NF-
kB decoy ODN affects maturation of DC. Therefore, DC
migration from the skin to LNs was first investigated by
topical application with FITC, because FITC has been used
not only as a hapten but also for cell tracking (Macatonia
et al., 1987). At 24 hours after NF-kB decoy, ODN was
applied to shaved abdominal skin, 0.5% FITC was painted on
the same area and draining LN cells were prepared after a
further 24 hours as described previously and stained with
phycoerythrin (PE)-conjugated CD11c. As shown in Figure
5a, migration of CD11cþFITCþ cells was decreased by
topical NF-kB decoy ODN application. When epidermal
sheets were stained with major histocompatibility complex II
(MHC II) after OVA sensitization following topical applica-
tion of NF-kB decoy ODN, a larger number of resident
Langerhans cells was observed than in the case with OVA
sensitization alone (data not shown). Interestingly, resident
Langerhans cells had an activated phenotype with longer
dendrites and enlarged cell size in NF-kB decoy ODN-
treated mice (data not shown). Further FACS analysis
revealed that topical NF-kB decoy ODN substantially inhibits
upregulation of CD80, CD86, and MHC II on FITC-positive
cells (Figure 5b).
Topical NF-jB decoy ODN inhibits antigen-specific T cell
proliferation by migrated DC
In order to assess the functions of DC from NF-kB decoy
ODN-treated mice, their stimulatory capacity for antigen-
specific T cells was examined. DC were isolated from LNs by
MACS (Miltenyi Biotec, Gladbach, Germany) using anti-
CD11c microbeads 24 hours after sensitization by OVA with
or without NF-kB decoy ODN and were co-incubated with
DO.11.10 CD4þ T cells expressing T cell receptors for MHC
II (I-Ad) plus OVA peptide (323–339) for 3 days. DC from
tolerant mice showed diminished secretion of IFN-g (Figure
5c). Scramble decoy ODN had no suppressive effect. The
results indicate that DC from NF-kB decoy ODN-treated
mice are at least functionally immature, although they do not
show the typical surface phenotype of iDC.
DISCUSSION
Regulation of DC maturation and Treg induction is a key to
tolerance induction. Here we showed that topical NF-kB
decoy ODN application induces Treg-mediated tolerance
against antigen-specific DTH by suppressing migration and
maturation of DC.
Recent studies have revealed that peripheral tolerance is
induced by iDC lacking expression of MHC-class II, co-
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Figure 3. Tolerance by NF-jB decoy ODN treatment is mediated by
CD4þCD25þ regulatory T cells (Treg). (a) Depletion of CD25þ T cells by
PC61 mAb. Mice were treated with or without topical NF-kB decoy ODN on
day 0 and sensitized on day 1 as described previously. On day 7, mice
received an intraperitoneal injection of 0.2 mg of PC61 mAb and then were
elicited on day 11 and DTH was assessed. *Po0.01 compared to NF-kB
decoy ODNþ PC61. **Po0.01 compared to sensitized mice. Induction of
CD4þCD25þ cells by NF-kB decoy ODN treatment. LN cells were prepared
from naı¨ve, sensitized, tolerant, and PC61-treated mice as described
previously and stained with PE-conjugated anti-CD4 and biotin-conjugated
anti-CD25 plus FITC-conjugated streptavidin. (b) naı¨ve mice, (c) OVA-
sensitized mice, (d) OVAþNF-kB decoyþ PC61, and (e) OVAþNF-kB
decoy. Data are representative dot plots and quadrant stats from three
independent experiments. (f) Mean fluorescence intensity of CD25 expression
in CD4þCD25þ cells. *Po0.05 compared to sensitized and naı¨ve mice.
0 50
Footpad swelling
(mm × 10−3)
100
NF-B
decoy
Day 0
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
–
–
–
–
–
–
–
–
–
–
–
– –
Day 1
Donor
Sensitization Sensitization ElicitationTransfer
Recipient
Day 7
CD4+CD25+
CD4+CD25+
CD4+CD25+
CD4+CD25–
CD4+CD25–
CD4+CD25–
Day 1 Day 8
∗
∗
Figure 4. Suppression of DTH by adoptive transfer of CD4þCD25þ
regulatory T cells (Treg). CD4þCD25þ and CD4þCD25 T cells were
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adoptive transfer. *Po0.03 compared to corresponding controls.
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stimulatory molecules, and immunostimulatory cytokines
(Lutz and Schuler, 2002). DC in peripheral tissues, such as
epidermal Langerhans cells, remain immature in the steady
state, expressing only a small quantity of MHC II and virtually
no co-stimulatory molecules. Once iDC capture antigens by
endocytosis, they migrate into T cell areas of regional LNs
and present processed antigenic peptides to T cells in the
context of MHC molecules (Inaba et al., 1997; Huang et al.,
2000; Lutz and Schuler, 2002). DC maturation simulta-
neously occurs during such processes, and they express high
amount of MHC II, co-stimulatory molecules and immunos-
timulatory cytokines. It is an established fact that mature DC
can activate T cells by delivering signals through T cell
receptor and co-stimulatory molecules (Viola and Lanzavec-
chia, 1996). Recent studies have, however, also revealed that
peripheral tolerance is induced by iDC lacking expression of
MHC II, co-stimulatory molecules, and immunostimulatory
cytokines (Steinman et al., 2000; Lutz and Schuler, 2002;
Nouri-Shirazi and Guinet, 2002). In addition, tolerance can
be induced by partially mature DC, which express MHC II,
CD80, and CD86 but lack secretion of IL-12, IL-6, and tumor
necrosis factor-a (Groux, 2003). Other groups have reported
that murine acute graft-versus-host disease can be prevented
by DC modified by 1a,25-dihydroxyvitamin D3 (Sato et al.,
2003) and that tolerance can be induced by the generation of
Treg by UV-damaged Langerhans cells in the contact
hypersensitivity model (Schwarz et al., 2004; Schwarz
et al., 2005). In our study, topical NF-kB decoy ODN
generated DC expressing a high level of MHC II, but
relatively low levels of co-stimulatory molecules, similar to
the case with DC treated with vitamin D3 (Sato et al., 2003).
Discordant upregulation between expression of MHC II and
co-stimulatory molecules in the sensitization phase may thus
be critical for induction of tolerance. It is well known that
individual surface molecules and cytokines have significant
roles in the induction of peripheral tolerance. However, this
may vary according to the peripheral environment such as
the severity of inflammation.
Several groups have investigated the links between DC
maturation and NF-kB activity using adenoviral transfection
of IkB or suppression of IkB kinase, and showed that
activated NF-kB plays significant roles in DC maturation
including the induction of co-stimulatory molecules and
cytokines such as IL-6 and IL-12 (Rescigno et al., 1998;
Yoshimura et al., 2001b). When NF-kB activity is artificially
suppressed using proteasome inhibitors, adenoviral transfec-
tion of IkB, or NF-kB decoy ODN, the antigen-presenting
functions of DC are also impaired, showing insufficient
expression of MHC II, co-stimulatory molecules (CD80,
CD86, and CD40), or immunostimulatory cytokines (IL-12
and tumor necrosis factor-a) (Yoshimura et al., 2001a;
O’Sullivan and Thomas, 2002). Another report documented
evidence that expression of a new co-stimulatory molecule
homologue B7-H also requires NF-kB (Li and Verma, 2002).
Recent data suggest that regulatory T cells play a key role
in peripheral tolerance (Takahashi et al., 1998; Shevach,
2001; Taylor et al., 2001; Thorstenson and Khoruts, 2001;
Zhang et al., 2001) under the influence of iDC or maturing
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Figure 5. Suppression of DC maturation by topical application of NF-jB
decoy ODN and impaired antigen-specific T cell stimulation by migrated
DC. (a) Twenty-four hours after application of NF-kB decoy ODN, mice were
painted with FITC on the abdominal skin. To analyze FITCþ migrated cells,
axillary, inguinal, and popliteal LNs were collected on the next day and stained
with PE-conjugated anti-CD11c mAb for FACS analysis. Data are presented as
the representative dot plots and as the mean percentage of CD11cþFITCþ
cells. *Po0.04 compared to FITC alone and scramble decoy-treated mice.
(b) Inhibition of DC differentiation by topical application of NF-kB decoy
ODN. LNs cells were collected after FITC application with or without NF-kB
decoy ODN, stained with PE-conjugated anti-CD80, CD86, or MHC II and
analyzed by FACS. Some mice were treated with scramble decoy ODN instead
of NF-kB decoy. Data are indicated as representative histograms and MFI was
obtained from three independent experiments. (c) Impaired antigen-specific T
cell stimulation by migrated DC after topical NF-kB decoy ODN. DC were
isolated by magnetic beads from draining LNs of OVA-sensitized BALB/c mice
treated with either NF-kB decoy ODN or scramble decoy ODN. CD4þ T cells
were isolated from the spleens of DO11.10 T cell receptor-transgenic mice
using MACS. DC (4 104 cells/well) and T cells (2105 cells/well) were co-
incubated in 96-well microplates for 72 hours. Release of IFN-g was assayed by
ELISA. Data indicate mean concentration of IFN-g (pg/ml). *Po0.05.
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DC (Min et al., 2003; Roelofs-Haarhuis et al., 2003). At
present, at least four regulatory T cells can be identified
based on expression of cell surface markers, secretion of
cytokines, and suppression mechanisms (Groux, 2003).
Here, we demonstrated that the pre-existing OVA-specific
CD4þCD25þ Treg are dominantly activated by NF-kB decoy
ODN plus OVA and induce antigen-specific tolerance to DTH
responses in vivo. These observations are in line with the
recent reports that immature and maturing DC can induce
proliferation of CD4þCD25þ T cells in an antigen-specific
manner both in vivo and in vitro (Walker et al., 2003;
Yamazaki et al., 2003). CD4þCD25þ Treg suppress bystan-
der T cells in an antigen nonspecific manner by direct cell-to-
cell interaction in vitro once they are activated (Thornton and
Shevach, 1998; Thornton and Shevach, 2000). However,
antigen-specific stimulation via T cell receptor is required for
the expansion and induction of suppressive properties of Treg
(Shevach, 2001). The suppression mode, whether antigen
specific or nonspecific, remains controversial (Shevach, 2001;
Sakaguchi, 2004). In this regard, the strategy employed in this
study provides a new path for antigen-specific tolerance
induced by CD4þCD25þ Treg.
Our data indicate that topical application of NF-kB decoy
ODN can suppress DC migration and maturation leading to
regulation of the immunostimulatory capacity. After NF-kB
decoy ODN treatment, a sizable DC population still remains
in the peripheral tissue after capturing exogenous antigen.
Even if these cells migrate into draining LNs, their presenta-
tion of antigens to T cells via MHC II is limited by insufficient
co-stimulatory signaling. Inadequate antigen presentation by
modified DC may lead to the induction of Treg. Here we
induced Treg through a combination of topical NF-kB decoy
ODN treatment and antigen stimulation. At present, we
consider that antigen stimulation of iDC without NF-kB
signaling is critical for the induction of tolerogenic DC that
can activate Treg efficiently.
In UV-induced tolerance to contact hypersensitivity,
intravenous transfer of Treg could not suppress contact
hypersensitivity challenge in sensitized mice (Schwarz
et al., 2004), which is distinct from our data. However, in
our study, secondary antigen sensitizations were performed
after adoptive transfer of Treg, while mice were elicited
immediately after transfer into UV-induced contact hyper-
sensitivity tolerance study. For tolerance induction, therefore,
antigen presentation by iDC or modified DC in the presence
of enriched Treg may be critical to prevent expansion of
effector cells.
A number of studies have proven that adoptive transfer of
allogeneic DC cultured with NF-kB decoy ODN prolongs
survival of cardiac allografts (Giannoukakis et al., 2000;
Bonham et al., 2002). However, this approach involves
considerable cost and time because DC must be isolated from
the peripheral blood, incubated with NF-kB decoy ODN in
vitro and then injected intravenously. In addition, this
method is only effective for immune tolerance to allogeneic
antigens. Here we demonstrated peripheral immune toler-
ance to two distinct antigens by a combination of antigen
stimulation and topical application of NF-kB decoy ODN.
This strategy is very simple and less expensive. Therefore,
application of this strategy might be able to regulate immune
responses against antigens that cause allergic or autoimmune
diseases if the responsible antigens can be identified.
The immune suppression induced by NF-kB decoy ODN
in the present study was restricted to the applied skin area.
Intravenous injection of tolerogenic DC may induce systemic
immune suppression effectively, but one distinct advantage of
tolerance induction by topical NF-kB decoy ODN treatment
may be the prevention of adverse effects associated with
systemic administration. Systemic suppression of NF-kB is
likely to be harmful, given that knockout mice for various NF-
kB signaling components suffer from immune deficiency or
lack lymphocyte activation (Morishita et al., 1997). In support
of this concept, a topical NF-kB decoy ODN treatment for
atopic dermatitis in mice was found to be highly effective
(Nakamura et al., 2002). In addition, it has been revealed that
cutaneous immunization with autoantigenic peptides pre-
vents experimental allergic encephalomyelitis (Bynoe et al.,
2003).
In conclusion, a new strategy to induce antigen-specific
peripheral tolerance by topical application of NF-kB decoy
ODN has great potential for the control of allergic diseases
and autoimmune disorders. Further studies of this approach
are clearly warranted.
MATERIALS AND METHODS
Animals
Female 6- to 12-week-old BALB/c mice were purchased from Japan
SLC (Hamamatsu, Japan). Mice transgenic for the OVA323–339-
specific and I-Ad-restricted DO11.10 T cell receptorab on a BALB/c
genetic background (Murphy et al., 1990) were kindly provided by
Dr K. Murphy (University of Washington, St, Louis, MO) via Dr
Y. Koide (Hamamatsu University School of Medicine, Hamamatsu,
Japan). All procedures with animals were carried out in accordance
with institutionally approved protocols, following the principles of
laboratory animal care formulated by the National Society for
Medical Research. Five mice were used in each group in all
experiments. At least three sets of experiments were performed
independently to obtain results.
Antibodies and reagents
FITC-conjugated anti-CD11c (HL3), FITC- or PE-conjugated anti-I-Ad
(2G9), and biotin-conjugated anti-CD25 (7D4) were purchased from
BD Biosciences Pharmingen (San Diego, CA), PE-conjugated anti-
CD80 (16-10A1), anti-CD86 (GL1), and anti-CD4 (GK1.5) mAb were
from e-Bioscience (San Diego, CA), FITC-conjugated streptavidin
was from EMD Biosciences, Inc. (San Diego, CA), and an anti-CD25
mAb (PC61) was kindly provided by Dr O. Taguchi (Aichi Cancer
Center Research Institute, Nagoya, Japan). The IgG fraction of anti-
CD25 (PC61) was obtained by protein G-Sepharose (Amersham
Biosciences, Piscataway, NJ). OVA and HEL (Sigma-Aldrich, St
Louis, MO) were used for sensitization and elicitation of DTH. FITC
isomer I was purchased from Sigma-Aldrich.
NF-jB decoy ODN
NF-kB decoy ODN ointment (2%) was prepared as described below.
NF-kB decoy or scramble ODN were synthesized by Qiagen
102 Journal of Investigative Dermatology (2006), Volume 126
I Isomura et al.
NF-kB Decoy ODN Induces Antigen-Specific Peripheral Tolerance
GmbH (Hilden, Germany), and mixed with 5% stearyl alcohol and
white petroleum. Their sequences were as follows (NF-kB binding
sequences underlined):
NF-kB decoy ODN
50-CCTTGAAGGGATTTCCCTCC-30
30-GGAACTTCCCTAAAGGGAGG-50
Scrambled ODN
50-TTGCCGTACCTGACTTAGCC-30
30-AACGGCATGGACTGAATCGG-50
The sequences of this NF-kB decoy ODN have been shown to bind
NF-kB (Morishita et al., 1997).
DTH assay and adoptive transfer
Time schedules for individual experiments are detailed in the
corresponding figures. Twenty milligrams of NF-kB ODN ointment
was applied on the shaved abdominal skin of BALB/c mice in each
case. Mice were sensitized by 1 mg OVA or 500mg HEL in an
emulsion of 100 ml phosphate buffered saline (PBS) (Sigma-Aldrich)
and 100 ml incomplete Freund’s adjuvant (Sigma-Aldrich), and DTH
was elicited with 100 mg OVA (2 mg/ml) or 50 mg HEL (4 mg/ml) in
PBS. Elicitation was performed by subcutaneous injection of antigens
into left footpads 7 days after final sensitization, if not otherwise
stated. Fifty microliters of PBS were injected into right footpads as a
negative control. Footpad swelling was assayed by the thickness of
the left footpad minus that of the right footpad at 24 or 48 hours after
elicitation. Footpad thickness was measured with a digimatic gauge
(Mitsutoyo Corporation, Kanagawa, Japan). For adoptive transfer
experiments, inguinal and popliteal LNs were harvested from mice 3
days after elicitation, mashed with slide glasses, and passed through
nylon mesh before centrifugation at 1,500 r.p.m. for 10 minutes.
After two washes, LN cells were suspended in PBS and injected into
tail veins (each mouse received 5 106 LN cells in 300ml of PBS
from one mouse).
Depletion of CD4þCD25þ T cells
Mice were injected with 0.2 mg PC61 mAb in 500 ml PBS
intraperitoneally as described previously (Onizuka et al., 1999;
Sakaguchi, 2004).
Isolation and adoptive transfer of CD4þCD25þ T cells
LN cells were prepared from sensitized or tolerant mice as described
above, and CD4þCD25þ T cells were positively separated from
CD4þCD25 T cells with a MACS CD4þCD25þ Regulatory T cell
isolation kit (Miltenyi Biotec, Gladbach, Germany). The percentages
of separated CD4þCD25 and CD4þCD25 T cells in the LN cells
were approximately 30 and 2%, respectively. Mice were sensitized
with OVA on day 0 and injected intraveneously with 2 105
CD4þCD25þ or CD4þCD25 T cells in 300ml PBS on day 6.
Elicitation followed on day 7.
Tracking assays for DC migration
Mice were painted with 0.5% FITC in 1:1 acetone/dibutyl phthalate
(400ml) (Sigma-Aldrich) 24 hours after topical application of NF-kB
decoy ODN. LN cells were prepared from axillary, inguinal, and
popliteal LNs and stained with PE-conjugated CD11c mAb. A possible
population containing DC was gated with forward and side scatters
and the percentage of CD11cþFITCþ cells was evaluated by FACS,
along with the expression of MHC II, CD80, and CD86 on FITCþ cells.
ELISA for IFN-c as a marker of stimulatory functions of migrated
DC
After the application of NF-kB decoy ODN or scramble decoy and
the sensitization with OVA, CD11cþ DC were isolated from cell
suspensions of LNs with anti-CD11c microbeads (Miltenyi biotec).
CD4þ T cells were isolated from splenocytes of DO11.10 transgenic
mice using the CD4þ T cell isolation kit (Miltenyi Biotec). CD4þ
T cells (2 105/well) were incubated with DC (4 104/well) in
96-well microplates (stimulator:responder ratio¼ 1:5). After 72 hours
incubation, release of IFN-g was assayed by ELISA (R&D systems,
Minneapolis, MN).
Flow cytometric analysis
Single-cell suspensions were prepared as described above and
blocked with rat or mouse IgG (Jackson ImmunoResearch Labora-
tories, Inc., West Grove, PA) on ice for 10 minutes before antibody
staining. Cells were then washed in Hank’s balanced salt solution
(Sigma-Aldrich) with 2% fetal bovide serum (Sigma-Aldrich) twice,
and stained with mAb on ice for 30 minutes. They were washed
twice and suspended in Hank’s balanced salt solution and analyzed
by FACScan (BD Biosciences Immunocytochemistry Systems, San
Diego, CA). In some experiments, cells were stained with FITC-
conjugated streptavidin (Jackson ImmunoResearch Laboratories)
after reaction with biotin-conjugated mAb.
Statistical analysis
All data were statistically analyzed using Student’s t-test. Bar graphs
are presented as mean7standard error of the mean value.
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